5-Year Data on Secukinumab in AS; Oliceridine Not Recommended for FDA Approval
Zilretta Promising for Blood Glucose Levels; Plus Filgotinib Promising for RA
Revised Application Expected for IV Meloxicam; Plus EU Approves Tildrakizumab
FDA Expands Safety Measures for Immediate Release Opioids
The FDA Denies Approval for Remoxy Extended Release; Plus Knee OA Pain Treatment Moves into Phase 3 Trials
EU Grants Marketing Authorization for Hyrimoz; Plus FDA Rejects New Drug Application for Buprenorphine Sublingual Spray
A Comprehensive Review of NSAID Cardiovascular Toxicity
FDA Approves Combination Therapy for OA Pain, but Not Duobrii Lotion for Plaque Psoriasis
IV Tramadol Promising for Postoperative Pain; FDA Denies IV Meloxicam Approval
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 13
- Next Page »